Doxycycline Hyclate

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

34 Suppliers, 17 USDMF, 9 CEP/COS, 1 JDMF, 2 EU WC, 2 KDMF, 17 NDC API, 19 Listed Suppliers

DEVELOPMENTS

23 Drug(s) in Development

23 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

DOSSIERs // Finished Dosage Forms

208 Dossiers, 175 FDA Orange Book, 2 Europe, 12 Canada, 19 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 150MG BASE, TABLET;ORAL - EQ 75MG BASE, TABLET;ORAL - EQ 100MG BASE, CAPSULE;ORAL - EQ 100MG BASE, CAPSULE;ORAL - EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, DELAYED RELEASE;ORAL - EQ 100MG BASE, CAPSULE, DELAYED RELEASE;ORAL - EQ 75MG BASE, SYSTEM, EXTENDED RELEASE;PERIODONTAL - 50MG, TABLET, DELAYED RELEASE;ORAL - EQ 100MG BASE, TABLET, DELAYED RELEASE;ORAL - EQ 120MG BASE, TABLET, DELAYED RELEASE;ORAL - EQ 150MG BASE, TABLET, DELAYED RELEASE;ORAL - EQ 200MG BASE, TABLET, DELAYED RELEASE;ORAL - EQ 50MG BASE, TABLET, DELAYED RELEASE;ORAL - EQ 60MG BASE, TABLET, DELAYED RELEASE;ORAL - EQ 75MG BASE, TABLET, DELAYED RELEASE;ORAL - EQ 80MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers, 40 Kerry, 33 BASF, 29 Roquette, 22 Microlex e.U, 17 SPI Pharma, 14 Seppic, 12 Gangwal Chemicals, 12 Gangwal Healthcare, 12 Actylis, 12 Sigachi Industries, 11 Corel Pharma Chem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 8 Ideal Cures Pvt Ltd, 7 Nanjing Well Pharmaceutical, 7 Boai NKY Pharmaceuticals Ltd, 7 DFE Pharma, 6 Lonza Capsugel, 5 Ingredion Pharma Solutions, 5 Kima Chemical, 4 Vasa Pharmachem, 4 ACG Worldwide, 4 The Dow Chemical Company, 4 Pharmatrans-Sanaq, 4 DKSH, 4 Prachin Chemical, 3 Finar, 3 Ulanqab Kema New Material, 3 Rochem International Inc, 2 Seqens, 2 Pfanstiehl, 2 Jai Radhe Sales, 2 Nomisma Healthcare, 2 Qualicaps, 2 Shijiazhuang Huaxu Pharmaceutical, 2 Aeon Procare, 1 Alcedo Pharmachem, 1 Vertellus, 1 Nanjing Bold Chemical, 1 Zhejiang Huakang Pharmaceutical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Clariant, 1 Shanghai Welltone Material Technology Co., Ltd

EXCIPIENTS BY APPLICATIONS

96 Fillers, Diluents & Binders, 63 Coating Systems & Additives, 46 Direct Compression, 44 Disintegrants & Superdisintegrants, 36 Controlled & Modified Release, 32 Granulation, 32 Thickeners and Stabilizers, 29 Solubilizers, 26 Parenteral, 26 Film Formers & Plasticizers, 25 Taste Masking, 21 Lubricants & Glidants, 18 Chewable & Orodispersible Aids, 17 Co-Processed Excipients, 17 Topical, 9 Empty Capsules, 8 API Stability Enhancers, 7 Rheology Modifiers, 6 Emulsifying Agents, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 2 Coloring Agents, 1 Soft Gelatin

GLOBAL SALES INFORMATION

44 US Medicaid Prescriptions, 18 Finished Drug Prices

MARKET PLACE

59 APIs, 1 DOSSIERS // FDF

PATENTS

14 US Patents

14 US Patents

ANALYTICAL SOLUTION(s)

2 EDQM Standards, 1 USP Standards, 1 Other Ref. Standards

DIGITAL CONTENT

1 Data Compilation & Company Tracker #PharmaFlow, 46 News

List of USP reference standards related to Doxycycline Hyclate

Doxycycline Hyclate

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

34 Suppliers

17 USDMF

9 CEP/COS

1 JDMF

2 EU WC

2 KDMF

17 NDC API

19 Listed Suppliers

DEVELOPMENTS

23 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

DOSSIERs // Finished Dosage Forms

208 Dossiers

175 FDA Orange Book

2 Europe

12 Canada

19 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 150MG BASE

TABLET;ORAL - EQ 75MG BASE

TABLET;ORAL - EQ 100MG BASE

CAPSULE;ORAL - EQ 100MG BASE

CAPSULE;ORAL - EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, DELAYED RELEASE;ORAL - EQ 100MG BASE

CAPSULE, DELAYED RELEASE;ORAL - EQ 75MG BASE

SYSTEM, EXTENDED RELEASE;PERIODONTAL - 50MG

TABLET, DELAYED RELEASE;ORAL - EQ 100MG BASE

TABLET, DELAYED RELEASE;ORAL - EQ 120MG BASE

TABLET, DELAYED RELEASE;ORAL - EQ 150MG BASE

TABLET, DELAYED RELEASE;ORAL - EQ 200MG BASE

TABLET, DELAYED RELEASE;ORAL - EQ 50MG BASE

TABLET, DELAYED RELEASE;ORAL - EQ 60MG BASE

TABLET, DELAYED RELEASE;ORAL - EQ 75MG BASE

TABLET, DELAYED RELEASE;ORAL - EQ 80MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers

40 Kerry

33 BASF

29 Roquette

22 Microlex e.U

17 SPI Pharma

14 Seppic

12 Gangwal Chemicals

12 Gangwal Healthcare

12 Actylis

12 Sigachi Industries

11 Corel Pharma Chem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

8 Ideal Cures Pvt Ltd

7 Nanjing Well Pharmaceutical

7 Boai NKY Pharmaceuticals Ltd

7 DFE Pharma

6 Lonza Capsugel

5 Ingredion Pharma Solutions

5 Kima Chemical

4 Vasa Pharmachem

4 ACG Worldwide

4 The Dow Chemical Company

4 Pharmatrans-Sanaq

4 DKSH

4 Prachin Chemical

3 Finar

3 Ulanqab Kema New Material

3 Rochem International Inc

2 Seqens

2 Pfanstiehl

2 Jai Radhe Sales

2 Nomisma Healthcare

2 Qualicaps

CAPSULE;ORAL - EQ 50MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons